Pharmacologic Aspects of S-adenosylmethionine. Pharmacokinetics and Pharmacodynamics
Overview
Authors
Affiliations
Several studies in animals have shown the efficacy of parenteral S-adenosylmethionine (SAMe) as an anti-inflammatory drug. In this article, data are reported on plasma kinetics, distribution, and metabolism of SAMe after oral administration since preference is given to oral dosage in the usual clinical practice. The results demonstrate the intestinal absorption of SAMe and its active metabolism. Experiments confirm the anti-inflammatory activity of the drug by the oral route. Results are also reported on the analgesic effect of SAMe.
Cameron B, Ferreira L, MacDonald I BMC Pharmacol Toxicol. 2020; 21(1):88.
PMID: 33317621 PMC: 7734772. DOI: 10.1186/s40360-020-00466-7.
Cuomo A, Beccarini Crescenzi B, Bolognesi S, Goracci A, Koukouna D, Rossi R Ann Gen Psychiatry. 2020; 19:50.
PMID: 32939220 PMC: 7487540. DOI: 10.1186/s12991-020-00298-z.
ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.
Webster C, Center S, Cullen J, Penninck D, Richter K, Twedt D J Vet Intern Med. 2019; 33(3):1173-1200.
PMID: 30844094 PMC: 6524396. DOI: 10.1111/jvim.15467.
S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
Sharma A, Gerbarg P, Bottiglieri T, Massoumi L, Carpenter L, Lavretsky H J Clin Psychiatry. 2017; 78(6):e656-e667.
PMID: 28682528 PMC: 5501081. DOI: 10.4088/JCP.16r11113.
Chien Y, Abdenur J, Baronio F, Bannick A, Corrales F, Couce M Orphanet J Rare Dis. 2015; 10:99.
PMID: 26289392 PMC: 4545930. DOI: 10.1186/s13023-015-0321-y.